Loading
Neurosurgeon-scientist who defined the four molecular subgroups of medulloblastoma that now guide therapy.
Michael Taylor led the international consensus that divided medulloblastoma into WNT, SHH, Group 3 and Group 4 subgroups, a classification adopted by the WHO that underpins current risk-stratified and de-escalated treatment trials. His laboratory showed that medulloblastoma metastases diverge genetically from the primary tumour and that the tumours spread via blood. He moved from SickKids Toronto to Texas Children's in 2023.
| Title | Journal | Year |
|---|---|---|
| Molecular subgroups of medulloblastoma: the current consensus | Acta Neuropathologica | 2012 |
| Intertumoral heterogeneity within medulloblastoma subgroups | Cancer Cell | 2017 |
Shares DNA methylation profiling, Medulloblastoma and the tags paediatric, medulloblastoma.
Shares Whole-exome & whole-genome sequencing and the tags paediatric, genomics.
Shares Whole-exome & whole-genome sequencing and the tag genomics.
Shares Whole-exome & whole-genome sequencing and the tag genomics.
Shares Whole-exome & whole-genome sequencing and the tag genomics.
Shares Whole-exome & whole-genome sequencing and the tag genomics.
Shares Whole-exome & whole-genome sequencing and the tag genomics.
Shares Whole-exome & whole-genome sequencing and the tag genomics.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/